Epilepsy in older adults: Common morbidities influence development, treatment strategies, and expected outcomes

Geriatrics

Volumn 60, Issue 12, 2005, Pages 30-34

  Rowan, A James ^a,b   Schachter, ^c,d   Sierzant, ^e   Sherman, ^a,f  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Harvard Osher Institute   (United States)

^e UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^f Department of Senior Health Partners ^*

Author keywords

Antiepileptic drugs (AEDs); Epilepsy; Geriatrics; Seizures elderly

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; STATINE DERIVATIVE; WARFARIN;

ADULT; AGED; ATAXIA; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; COMORBIDITY; CONFUSION; DEMENTIA; DIABETES MELLITUS; DRUG EFFECT; DRUG SAFETY; DRUG TOXICITY; EPILEPSY; FROZEN SHOULDER; GAIT DISORDER; GINGIVA HYPERTROPHY; HEART DISEASE; HUMAN; HYPERTENSION; HYPONATREMIA; KIDNEY DISEASE; LIVER DYSFUNCTION; ORGAN SYSTEM TOXICITY; OSTEOPOROSIS; PANCYTOPENIA; PATIENT MONITORING; PERIPHERAL NEUROPATHY; POLYPHARMACY; PROBABILITY; REVIEW; SOFT TISSUE DISEASE; TREMOR; UNCONSCIOUSNESS;

AGED; ANTICONVULSANTS; CHRONIC DISEASE; EPILEPSY; HEALTH STATUS; HUMANS; MIDDLE AGED; MORBIDITY; TREATMENT OUTCOME;

EID: 29244487536     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. CDC/National Center for Health Statistics, 1995 National Health Interview Survey (unpublished data). Available at: http://www.cdc.gov/mmwr/preview/m mwrhtml/ss4808a2.htm. Accessed November 29, 2005.
2. Rowan AJ, Ramsay RE, Collins JF, et al; VA Cooperative Study 428 Group. New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine and carbamazepine. Neurology 2005; 64(11):1868-73.
3. Romanelli MF, Morris J, Askin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990; 47(8):847-50.
4. Hauser WA. Epidemiology of seizures and epilepsy in the elderly. In: Rowan AH, Ramsay RE (eds). Seizures and epilepsy in the elderly. Boston: Butterworth-Heinemann, 1997:7-20.
5. Cramer JA. Identifying and improving compliance patterns: a composite plan for health care providers. In: Cramer JA, Spilker B, Eds. Patient Compliance in Medical Practice and Clinical Trials. New York:Raven Press; 1991:387-392.
6. Rowe JW, Kahn RL. Successful Aging. New York, Pantheon Books, 1998.
7. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313(3):145-151.
8. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992; 327(11):765-71.
9. Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriatr Med 1990; 6(2):269-83.
10. Cloyd J. Commonly used antiepileptic drugs: Age-related pharmacokinetics. In: Rowan AJ, Ramsay RE. Seizures and Epilepsy in the Elderly. Boston: Butterworth-Heinemann, 1998, 219-28.
11. Rowan AJ. Valproate. In: Engel J Jr, Pedley TA, eds. Epilepsy, A Comprehensive Textbook. Philadelphia, Lippencott-Raven 1998, 1599-1608.
12. Klenfeld M, Casimir M, Borra S. Hyponatremia as observed in a chronic disease facility. J Am Geriatr Soc 1979; 27(4):156-61.
13. Leppik IE, Wolff D. Drug interactions in the elderly with epilepsy. In: Rowan AJ, Ramsay RE. Seizures and Epilepsy in the Elderly. Boston: Butterworth-Heinemann, 1998, 291-302.